GoHealth, Inc.

As of March 31, 2026, GoHealth, Inc. carries a market capitalization of 24.51M, placing it among publicly traded companies globally. Its enterprise value stands at 601.83M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

GoHealth, Inc.'s next confirmed earnings release is scheduled for August 6, 2026.

As of March 31, 2026, GoHealth, Inc. has 16.23M shares outstanding.

These figures are as of March 31, 2026. The price-to-sales ratio is 0.14, and the price-to-book ratio stands at 11.50.

These figures are as of March 31, 2026. The EV/Sales ratio of 3.94 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. These enterprise value multiples are built on an enterprise value of 601.83M versus a market cap of 24.51M, with the gap driven by net debt and cash on the balance sheet.

As of March 31, 2026, GoHealth, Inc. maintains a current ratio of 2.03, meaning it holds 2.0x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is -1,000.35, indicating conservative leverage, while an interest coverage ratio of -3.92 demonstrates limited ability to service its debt obligations.

Over the twelve months ended March 31, 2026, GoHealth, Inc. posted a negative return on equity (ROE) of -241.12, meaning shareholder capital produced losses rather than profits. Return on assets (ROA) is negative at -25.21, reflecting losses generated across the asset base. The company generates approximately 98,223.72 in revenue per employee across its workforce of 1,555.50, a quick read on workforce productivity versus industry peers.

Over the twelve months ended March 31, 2026, GoHealth, Inc. recorded an income tax benefit of -3.72M rather than an expense, typically from losses, carryforwards, or the release of a tax provision. The company reported a pretax loss of -557.83M and -289.89M in bottom-line net income, so the effective tax rate carries little signal until profitability returns.

As of the close on July 21, 2026, GoHealth, Inc.'s stock has declined approximately 94.01% over the past 52 weeks. The 50-day moving average sits at 0.52, while the 200-day moving average is 1.93.

Over the twelve months ended March 31, 2026, GoHealth, Inc. generated 152.79M in revenue and converted that into -289.89M in net income, yielding earnings per share of -38.65. EBITDA reached -400.43M, while operating income came in at -195.11M.

As of March 31, 2026, GoHealth, Inc. holds 39.88M in cash and equivalents against 688.12M in total debt, resulting in a net debt position of 613.25M. Total book value stands at 2.13M, with working capital of 134.67M providing operational flexibility.

GoHealth, Inc. produced -102.56M in operating cash flow over the twelve months ended March 31, 2026. After subtracting -5.20M in capital expenditures, free cash flow totaled -107.76M - equivalent to -7.52 per share.

Over the twelve months ended March 31, 2026, GoHealth, Inc. posted a gross margin of 57.34, reflecting its pricing power and cost economics. The operating margin of -127.70 and net profit margin of -189.73 provide insight into operational efficiency.

These figures cover the twelve months ended March 31, 2026. The dividend payout ratio of 0.49 indicates the proportion of earnings distributed to shareholders, a key gauge of how sustainable the dividend is and how much room remains for future dividend growth. Free cash flow yield is negative at -497.70: the business is consuming cash rather than generating it, so any dividend is not covered by free cash flow. Total shareholder yield is negative at -510.73, meaning GoHealth, Inc. raised more capital through share issuance and new debt than it returned via dividends and buybacks.

GoHealth, Inc.'s most recent stock split took place on November 18, 2022 with a 15:1 split ratio.

As of March 31, 2026, GoHealth, Inc. has an Altman Z-Score of -1.44, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.